About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Slc2a9
solute carrier family 2 (facilitated glucose transporter), member 9
MGI:2152844
49 phenotypes from 3 alleles in 4 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Slc2a9tm1.1Thor/Slc2a9+
Albtm1(cre/ERT2)Mtz/Alb+
involves: 129S2/SvPas * C57BL/6 * C57BL/6N 		increased urine magnesium level J:153089
increased urine phosphate level J:153089
Slc2a9tm1.1Thor/Slc2a9tm1.1Thor
Albtm1(cre/ERT2)Mtz/Alb+
involves: 129S2/SvPas * C57BL/6 * C57BL/6N 		decreased urine osmolality J:153089
decreased urine pH J:153089
increased blood uric acid level J:153089
increased urine magnesium level J:153089
increased urine phosphate level J:153089
increased urine potassium level J:153089
polyuria J:153089
normal renal/urinary system phenotype J:153089
uraturia J:153089
Slc2a9tm1.2Thor/Slc2a9+
involves: C57BL/6 * C57BL/6N 		increased circulating magnesium level J:153089
increased urine sodium level J:153089
Slc2a9tm1.2Thor/Slc2a9tm1.2Thor
involves: C57BL/6 * C57BL/6N 		abnormal renal reabsorption J:153089
decreased body weight J:153089
decreased urine osmolality J:153089
decreased urine pH J:153089
dilated renal tubule J:153089
hydronephrosis J:153089
increased blood uric acid level J:153089
increased circulating creatinine level J:153089
increased circulating magnesium level J:153089
increased urine magnesium level J:153089
increased urine potassium level J:153089
increased urine sodium level J:153089
kidney cortex atrophy J:153089
kidney cortex cyst J:153089
kidney inflammation J:153089
nephrolithiasis J:153089
polydipsia J:153089
polyuria J:153089
prenatal lethality, incomplete penetrance J:153089
renal interstitial fibrosis J:153089
renal tubule atrophy J:153089
tubulointerstitial nephritis J:153089
uraturia J:153089
Slc2a9tm1Khm/Slc2a9tm1Khm
involves: 129 * C57BL/6 		no abnormal phenotype detected J:221544
Slc2a9tm1Khm/Slc2a9tm1Khm
Tg(Vil1-cre)997Gum/0
involves: 129 * C57BL/6 * C57BL/6J 		abnormal circulating lipid level J:221544
abnormal enterocyte physiology J:221544
abnormal feces composition J:221544
abnormal heart echocardiography feature J:221544
abnormal metabolism J:221544
decreased respiratory quotient J:221544
hepatic steatosis J:221544
hypertension J:221544
increased basal metabolism J:221544
increased blood uric acid level J:221544
increased body fat mass J:221544
increased circulating cholesterol level J:221544
increased circulating free fatty acids level J:221544
increased circulating insulin level J:221544
increased circulating triglyceride level J:221544
increased energy expenditure J:221544
increased heart rate J:221544
increased liver free fatty acids level J:221544
increased liver triglyceride level J:221544
increased oxygen consumption J:221544
increased percent body fat/body weight J:221544
increased urine uric acid level J:221544
insulin resistance J:221544
liver fibrosis J:221544
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory